The objective of this proposal is to develop a new candidate recombinant protein vaccine for the new coronavirus disease 2019 (COVID-19) based on a novel protein delivery and adjuvant technology, iPDT. If successful, this research will advance another COVID-19 vaccine candidate(s) to the pipeline toward clinical use. The causative agent of COVID-19 is SARS coronavirus […]
Read More